Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

NSC-249992

Known as: NSC 249992, NSC249992 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1983
1983
The clinical pharmacology of 4'-(9-acridinylamino)methanesulfon-m-anisidide (amsacrine) was studied, utilizing [9-14C]amsacrine i… Expand
1982
1982
s (13) Pavkov, K . L ., D . C. Thake and C. R . Hassler: Toxicology of D-Amygdalin (NSC-15780) and D ,L Amygdalin (NSC-251222) in… Expand
  • figure 2
Highly Cited
1982
Highly Cited
1982
Quantitative relationships (QSAR) have been derived between antileukemic (L1210) activity and agent physicochemical properties… Expand
1981
1981
The sensitivities of hematopoietic colony-forming cells (CFC) to N-[4-(9-acridinylamino)-3-methoxyphenyl]-methanesulfonamide (NSC… Expand
1981
1981
Abstract Dermal rashes appearing in personnel involved in the bulk formulation of the antineoplastic agent AMSA prompted this… Expand
1980
1980
4'-(9-Acridinylamino)methanesulfon-m-anisidide (m-AMSA; NSC-249992) is a new anticancer agent that has undergone extensive… Expand
1979
1979
4'-(9-Acridinylamino)methanesulfon-m-anisidide (m-AMSA, NSC 249992), an acridine derivative, was given to 28 patients with solid… Expand
Highly Cited
1978
Highly Cited
1978
The compound 4'-(9-acridinylamino)methanesulfon-m-anisidide is a new derivative that was evaluated in a Phase 1 clinical trial… Expand